» Articles » PMID: 714117

Fallacy of the Five-year Survival in Lung Cancer

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1978 Dec 21
PMID 714117
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Patients with lung cancer can be treated by either surgical extirpation or radiation. The former may offer increased five-year survival and prolonged life expectancies as compared to the latter, but subjects patients to the immediate risk of thoracotomy. We interviewed patients with "operable" lung cancer and found that they were quite averse to taking risks involving the possibility of immediate death. When these data about patients' attitudes were combined with data about survival after both radiation therapy and operation, it appeared that radiotherapy would be the preferred therapeutic plan for several of these patients. These results emphasize the importance of choosing therapies not only on the basis of objective measures of survival but also on the basis of patient attitudes.

Citing Articles

Identification of prognostic immune subtypes of lung squamous cell carcinoma by unsupervised consistent clustering.

Wang Y, Hou L, Yang M, Fan J, Wang Y, Sun L Medicine (Baltimore). 2023; 102(37):e35123.

PMID: 37713826 PMC: 10508570. DOI: 10.1097/MD.0000000000035123.


Monetary values of increasing life expectancy: Sensitivity to shifts of the survival curve.

Hammitt J, Tuncel T J Risk Uncertain. 2023; :1-31.

PMID: 37360985 PMC: 10171170. DOI: 10.1007/s11166-023-09406-2.


Association of Operability With Post-Treatment Mortality in Early-Stage Non-Small Cell Lung Cancer.

Stokes W, Xiong N, Liu Y, Higgins K, Tian S, Bradley J Clin Lung Cancer. 2022; 23(3):e231-e237.

PMID: 35093293 PMC: 9106833. DOI: 10.1016/j.cllc.2021.12.012.


Preference-Sensitive Management of Post-Mammography Decisions in Breast Cancer Diagnosis.

Ayvaci M, Alagoz O, Ahsen M, Burnside E Prod Oper Manag. 2019; 27(12):2313-2338.

PMID: 31031555 PMC: 6481963. DOI: 10.1111/poms.12897.


Combined analysis identifies six genes correlated with augmented malignancy from non-small cell to small cell lung cancer.

Zhang C, Min L, Zhang L, Ma Y, Yang Y, Shou C Tumour Biol. 2015; 37(2):2193-207.

PMID: 26349752 DOI: 10.1007/s13277-015-3938-5.